Insider Profile
Assabgui, Robert
2
Companies Filed At
1
Open-Market Buys (2yr)
$100K
Buy Value (2yr, open-market)
Apr 27, 2026
Most Recent Trade
5
Credibility
Score
38%
Hit Rate
-14.9%
Avg 90d Return
-28.2%
Median 90d Return
8
Evaluated Trades
+7.3%
Best Trade
-28.2%
Worst Trade
Hit rate and returns are based on 8 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
Hit Rate · 90d
-27.7%
Median Alpha · 90d
1
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 1 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Apr 27, 2026 $NFG
New Found Gold Corp.
Open Market Buy 33,780 $2.96 $100K 60
Sep 15, 2025 $NFG
New Found Gold Corp.
Other Sell 60
Feb 28, 2022 $HBM
Hudbay Minerals
Comp. Grant Buy 15,279 86
Feb 28, 2022 $HBM
Hudbay Minerals
Exercise Sell 13,142 $3.76 $49K 86
Feb 28, 2022 $HBM
Hudbay Minerals
Open Market Buy 13,142 $9.67 $127K 86
Feb 28, 2022 $HBM
Hudbay Minerals
Exercise Buy 13,142 $3.76 $49K 86
Feb 28, 2022 $HBM
Hudbay Minerals
Comp. Grant Buy 8,604 86
Feb 28, 2022 $HBM
Hudbay Minerals
Comp. Grant Buy 17,208 86
Dec 31, 2021 $HBM
Hudbay Minerals
Plan / DRIP Buy 6,754 $8.68 $59K 86
Dec 31, 2021 $HBM
Hudbay Minerals
Other Sell 25,948 $9.10 $236K 86
Dec 31, 2021 $HBM
Hudbay Minerals
Plan / DRIP Buy 149 86
Dec 31, 2021 $HBM
Hudbay Minerals
Plan / DRIP Buy 142 86
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.